Patrick J. Balthrop

Patrick J. Balthrop discloses dealings in Maxcyte, Inc. to SEC (Form 4). In total, 3 filings cover trades dated from 11 June 2024 to 17 June 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The newest entry dates from 22 June 2026: a share grant, in Maxcyte, Inc. Typically, a trade is published a median of 5 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.